Skip to search formSkip to main contentSkip to account menu

teneligliptin

Known as: ((2S,4S)-4-(4-(3-Methyl-1-Phenyl-1H-Pyrazol-5-yl)Piperazin-1-yl)Pyrrolidin-2-yl)(1,3-Thiazolidin-3-yl)Methanone 
A long-acting, orally bioavailable, pyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Teneligliptin may also… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background DPP-4 inhibitors showed analgesic and anti-inflammatory activity in human and animal-studies. DPP-4 inhibitors… 
2020
2020
Objectives: The purpose of this study was to investigate the efficacy and safety of teneligliptin, a completely unique and highly… 
2020
2020
Background: Teneligliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor, available in India. It has been widely prescribed in… 
2019
2019
Introduction: Type 2 diabetes mellitus is one of the most common non-communicable diseases associated with short term and long… 
2019
2019
Introduction: Type 2 diabetes mellitus (T2DM) with chronic kidney disease (CKD) is dreadful combination necessitating adequate… 
2018
2018
Background: In patient with type 2 diabetes (T2D) inadequately controlled on monotherapy, teneligliptin is efficacious and safe… 
2018
2018
Background: Diabetes is a significant health burden and is emerging as a pandemic. Teneligliptin, oral DPP-4 inhibitor was… 
2017
2017
Background: Teneligliptin was introduced in India in May 2015. It has gained popularity and is already widely prescribed in type… 
2015
2015
The present invention discloses a preparation method of a teneligliptin key intermediate 1-(3-methyl-1-phenyl-1H-pyrazol-5-yl… 
2014
2014
A simple, rapid, precise and accurate isocratic reversed-phase stability-indicating HPLC method was developed and validated for…